BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8894823)

  • 1. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET).
    Heald AE; Hoffman JM; Bartlett JA; Waskin HA
    Int J STD AIDS; 1996; 7(5):337-46. PubMed ID: 8894823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of FDG-PETCT and magnetic resonance spectroscopy in differentiating between cerebral lymphoma and non-malignant CNS lesions in HIV-infected patients.
    Westwood TD; Hogan C; Julyan PJ; Coutts G; Bonington S; Carrington B; Taylor B; Khoo S; Bonington A
    Eur J Radiol; 2013 Aug; 82(8):e374-9. PubMed ID: 23578921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS.
    Skiest DJ; Erdman W; Chang WE; Oz OK; Ware A; Fleckenstein J
    J Infect; 2000 May; 40(3):274-81. PubMed ID: 10908023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.
    Hoffman JM; Waskin HA; Schifter T; Hanson MW; Gray L; Rosenfeld S; Coleman RE
    J Nucl Med; 1993 Apr; 34(4):567-75. PubMed ID: 8455072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients.
    Ciricillo SF; Rosenblum ML
    J Neurosurg; 1990 Nov; 73(5):720-4. PubMed ID: 2213162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients].
    Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A
    Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of fluorodeoxyglucose-positron emission tomography for the differentiation of cerebral lesions in patients with acquired immune deficiency syndrome.
    Menendez JA; Lilien DL; Nanda A; Polin RS
    Neurosurg Focus; 2000 Feb; 8(2):e2. PubMed ID: 16869549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system lymphoma in the acquired immunodeficiency syndrome.
    Morgello S; Petito CK; Mouradian JA
    Clin Neuropathol; 1990; 9(4):205-15. PubMed ID: 2171824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stereotactic brain biopsy in the diagnosis of focal brain lesions in AIDS].
    Corti M; Metta H; Villafañe MF; Yampolsky C; Schtirbu R; Sevlever G; Garrido D
    Medicina (B Aires); 2008; 68(4):285-90. PubMed ID: 18786884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal neurological disease in patients with acquired immunodeficiency syndrome.
    Skiest DJ
    Clin Infect Dis; 2002 Jan; 34(1):103-15. PubMed ID: 11731953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonmalignant lesions in AIDS patients.
    Lorberboym M; Wallach F; Estok L; Mosesson RE; Sacher M; Kim CK; Machac J
    J Nucl Med; 1998 Aug; 39(8):1366-9. PubMed ID: 9708509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
    Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
    Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system dysfunction in acquired immunodeficiency syndrome.
    Levy RM; Bredesen DE
    J Acquir Immune Defic Syndr (1988); 1988; 1(1):41-64. PubMed ID: 3063805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of MR imaging and FDG-PET/CT in the differential diagnosis of benign and malignant vertebral compression fractures.
    Cho WI; Chang UK
    J Neurosurg Spine; 2011 Feb; 14(2):177-83. PubMed ID: 21214309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of imaging, clinical, and pathologic aspects of space-occupying lesions within the brain in patients with acquired immune deficiency syndrome.
    Gill PS; Graham RA; Boswell W; Meyer P; Krailo M; Levine AM
    Am J Physiol Imaging; 1986; 1(3):134-41. PubMed ID: 3451758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature.
    Levy RM; Bredesen DE; Rosenblum ML
    J Neurosurg; 1985 Apr; 62(4):475-95. PubMed ID: 2983051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal Intramedullary Spinal Cord Lesion in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Toxoplasmosis Versus Lymphoma.
    Mohole J; Ho AL; Sussman ES; Pendharkar AV; Lee M
    World Neurosurg; 2019 Jul; 127():227-231. PubMed ID: 30981796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary lymphoma of the central nervous system in children with acquired immunodeficiency syndrome.
    Esptein LG; DiCarlo FJ; Joshi VV; Connor EM; Oleske JM; Kay D; Koenigsberger MR; Sharer LR
    Pediatrics; 1988 Sep; 82(3):355-63. PubMed ID: 3261418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radionuclide brain imaging in acquired immunodeficiency syndrome (AIDS).
    Costa DC; Gacinovic S; Miller RF
    Q J Nucl Med; 1995 Sep; 39(3):243-9. PubMed ID: 7552947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.
    Travaini LL; Petralia G; Trifirò G; Ravasi L; Galetta D; Carbone G; Falcini F; Spaggiari L; Bellomi M; Paganelli G
    Lung Cancer; 2008 Sep; 61(3):362-8. PubMed ID: 18358558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.